Debt to EBITDA ratio Analysis of Balaxi Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsDebt to EBITDA of BALAXI
Mar-251.54Very Good Debt to EBITDA | Mar-243.35Indecisive Debt to EBITDA | Growth-53.92% |
Debt to EBITDA Analysis of Balaxi Pharmaceuticals Ltd.
| Debt to EBITDA Ratio 1.54 of Balaxi Pharmaceuticals Ltd. shows that the company is financially strong and has enough profit to pay off its debt. |
| Debt to EBITDA Ratio of BALAXI drastically fell by -53.92 % this year. |
| Debt to EBITDA Ratio with value of 3.35 was highest in Year Mar-24 in last Five Years. |
| Debt to EBITDA Ratio with value of 0.066 was lowest in Year Mar-22 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of 1.54 is Greater than Average Debt to EBITDA of 1.05 in last five years. |
Other Debt to EBITDA Related Info of BALAXI that may interest you.
Balaxi Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BALAXI | 43.08 | 42.94 | 0.326 % | Misc Fin Services |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Excellent Stability | Screener |
FY - Historical Debt to EBITDA of Balaxi Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | 1.54 | 3.35 | 0.196 | 0.066 | 0.082 | 0 | 0 |
| Change | -53.92 % | 1603.34 % | 197.80 % | -19.55 % | |||
| Price | 63.92 | 99.19 | 106.07 | 70.32 | 104.90 | 14.80 | 7.60 |
| Price Change | -35.56 % | -6.49 % | 50.84 % | -32.96 % | 608.78 % | 94.74 % | 156.76 % |